Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
News
Latests Medical News from around the world and also Thailand, bringing you updates, discoveries, studies and findings on various aspects and diseases in the medical world. Most of these articles are not only meant for Doctors In Thailand or Hospitals In Thailand but also for any patients or health conscious individuals wanting to know more.
Source: Medical News - SARS-CoV-2 Research  Dec 01, 2021  2 years ago
A new study by researcher from La Trobe University-Australia, Swinburne University of Technology-Australia, ETH Zurich University -Switzerland and the University of Luxembourg has shockingly found that SARS-CoV-2 protein fragments themselves possess neurotoxic properties and are dangerous for the human host. These amyloidogenic peptides are capable of causing a variety of neurological issues in th...
Source: Medical News - SARS-CoV-2 Airborne Transmissions  Dec 01, 2021  2 years ago
A new study by researchers from Stony Brook University, New York-USA has shown that that stale air and low wind speeds are associated with higher COVID-19 incidences. The study focused as to whether outdoor transmission may contribute to the COVID-19 epidemic. The study team hypothesized that slower outdoor wind speed is associated with increased risk of transmission when individuals socialize ou...
Source: Medical News  Nov 30, 2021  2 years ago
Moderna’s CEO Stéphane Bance has predicted that existing vaccines will be much less effective at tackling the Omicron variant than earlier strains of the SARS-CoV-2 coronavirus and warned it would take months before pharmaceutical companies could manufacture new variant-specific jabs at scale.  In the meanwhile, the pandemic coud take for a more catastrosphic turn with millions...
Source: Omicron Updates  Nov 30, 2021  2 years ago
Both Japan and France confirmed their first cases of the new variant of the coronavirus on Tuesday as countries around the world scrambled to close their doors or find ways to limit its spread while scientists study how damaging it might be.   To date a total of 17 countries outside of the African continent have confirmed cases of the new Omega (Omicron) variant. These countries include Aust...
Source: Medical News- Omega (Omicron) Variant Updates  Nov 30, 2021  2 years ago
India Reports First Case Of Omega (Omicron) Variant   Indian health officials have reported that a 32-year-old resident of Dombivli in Mumbai, who arrived from South Africa via Delhi on November 24, tested positive upon arrival.   Officials of the Kalyan Dombivli Municipal Corporation (KDMC) said they have alerted the airport authorities and efforts are on to locate the man&r...
Source: Medical News - SARS-CoV-2 & Kidneys  Nov 30, 2021  2 years ago
More and more data are daily emerging that the SARS-CoV-2 coronavirus is able to cause a wide range of health conditions in both those struggling with an infection and even more so in those who have been deemed as recovered based on a stupid nasal swab test!   A whole wide range of conditions emerging include lung damage, heart issues and heart failure, a whole wide range of neurological iss...
Source: COVID-19 Research-Aging  Nov 29, 2021  2 years ago
COVID-19 Research: A new study by researcher from Harvard Medical School has found that severe COVID-19 may result in premature aging in recovered patients.   Although COVID-19 is predominantly an acute respiratory disease caused by the SARS-CoV-2 coronavirus and remains a significant threat to public health, it is often accompanied by neurological symptoms and cognitive decline.   The ...
Source: Omicron Updates  Nov 29, 2021  2 years ago
Omicron Updates: As of 7pm, Monday Evening (Bangkok), The Omega (Omicron) or the B.1.1.529 variant has been detected in a total of 13 countries including Austria, Australia, Belgium, Canada, Czech Republic, Denmark, Germany, Hong Kong, Israel, Italy, Netherlands, Portugal and the United Kingdom.   In the African continent, it has now been confirmed in Nigeria besides Botswana and South Afric...
Source: Omega (Omicron) Variant  Nov 29, 2021  2 years ago
The WHO or World Health Organization (WHO) said in a statement a few hours ago (Monday 29th November) that the Omega (Omicron) variant poses a “very high” global risk and could change the course of the pandemic and have severe consequences.   The WHO said that the new variant is likely to spread internationally very rapidly and that countries must start preparing for the worse as...
Source: COVID-19 Drug Scams-Favipiravir  Nov 29, 2021  2 years ago
Since the beginning of the pandemic, certain countries like China and Japan were advocating the use of Favipravir (Avigan) to treat COVID-19 despite lack of evidence to show its efficacy. Surprisingly, although China was advocating its use to other countries by giving and selling stocks of the drug, it was never really endorsed in its own national guidelines for COVID-19 treatment neither was it u...
Source: Omega B.1.1.529 Variant  Nov 29, 2021  2 years ago
The Omega Variant or B.1.1.529 Variant (Thailand Medical News refers to the variant as Omega and not the stupidly WHO designated name: Omicron) has to date been confirmed in Hong Kong, Israel, Italy, Germany, Belgium, UK, Australia, Czech Republic, Denmark, Netherlands and recently in Canada. There are also suspected cases in at least another 17 countries now with confirmations pending upon result...
Source: COVID-19-Tuberculosis  Nov 28, 2021  2 years ago
COVID-19-Tuberculosis: Researchers from Necmettin Erbakan University-Turkey and the Meram Medical Faculty Hospital-Turkey are warning that based on actual clinical case studies and reports of pediatric patients in their hospital, they are witnessing cases of dormant tuberculosis being reactivated in individuals including children as a result of a COVID-19 infection.   The COVID-19 disease is...
Source: Omega Variant  Nov 28, 2021  2 years ago
The Omega Variant (We have decided to forego the stupid name bestowed on the B.1.1.529 by the incompetent and even more stupid entity ie the WHO, which has to date been one of the most hopeless agency from day one that the SARS-CoV-2 virus was discovered. In fact, we are still not sure why any media or anyone would be interested to listen to what these bunch of inept morons have to say! The world ...
Source: COVID-19-Diagnostics  Nov 28, 2021  2 years ago
COVID-19-Diagnostics: A new study by researchers from the University of Montreal-Canada has shown that measuring the amount of viral RNA in the blood is a reliable indicator of COVID-19 mortality risk.   To date, despite advances in COVID-19 management, identifying patients evolving toward death remains challenging.   In order the to identify early predictors of mortality within 60 days...
Source: Omicron variant  Nov 28, 2021  2 years ago
The United Kingdom in the last few hours Britain confirmed its first two cases of the new Omicron strain of COVID-19, both linked to travel from southern Africa, and expanded travel restrictions on the region.   A British government statement said, "After overnight genome sequencing, the UK Health Security Agency has confirmed that two cases of COVID-19 with mutations consistent with B....
Source: Omicron Variant Origin  Nov 27, 2021  2 years ago
Speculations are going around that the highly vaccinated United Kingdom might be the source of the Omicron or B.1.1.529 variant and we need the help of investigative researchers and journalists to verify this.   Initially South African health authorities and health experts said that based on online genomic data, the Omicron strain might have originated from Botswana.   However, the Botsw...
Source: Omicron or B.1.1.529 Variant  Nov 27, 2021  2 years ago
Initially in the early part of the day, a German minister in the western state of Hesse had indicated that the Omicron variant of COVID-19 has probably arrived in Germany, after mutations were found in a passenger arriving from South Africa.   Kai Klose, social affairs minister in Hesse, home to Frankfurt airport, Germany's biggest hub and one of Europe's busiest airports tweeted, &q...
Source: SARS-CoV-2 Variants  Nov 27, 2021  2 years ago
It was fun to see the type of reactions taking place in the last 48 hours over the identification of the Omicron or B.1.1.529 variant that has a total of 59 mutations found on it including 32 on its spike proteins.   Despite the vast number of mutations on its genome and the fact that it is still stable, there is no real need to get alarmed and panic as the reality of the situation is that m...
Source: B.1.1.529 Omicron Variant  Nov 27, 2021  2 years ago
The WHO or World Health Organization has in the last few hours classified the B.1.1.529 variant as a Variant of Concern (VOC) and also renamed it as the Omicron variant.   The great news is that this highly transmissible variant that is definitely immune and vaccine evasive due to the constellation of the 32 mutations found just on its spike mutations and another 27 on the rest of its genome...
Source: B.1.1.529  Nov 27, 2021  2 years ago
Health authorities in Belgium have confirmed that Europe’s first case of the new B.1.1.529 variant has been detected in the country.   Interestingly barely an hour after the UK health secretary, Sajid Javid had imposed new restrictions on travel from South Africa and five other nearby countries and also warned it was highly likely the new variant has spread further than ...
Source: COVID-19 Prophylactics-Therapeutics  Nov 26, 2021  2 years ago
COVID-19 Prophylactics-Therapeutics: Researchers from the University of Tennessee Health Science Center-USA and Instituto de Ciencia y Tecnología-Argentina have in a new study demonstrated that a combination of iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture, paving the way for the development of a prophylactic and therapeutic nasal spray for COVID-19.   Since the...
Source: Medical News - Research  Nov 26, 2021  2 years ago
Researchers when conducting and submitting papers for publishing with regards to potential prophylactics and therapeutics should also mention the type of strains or variants of SARS-Cov-2 used in their studies as it is now clearly emerging that different strains and variants have different characteristics and even pathogenesis modes.   Even in the case of antivirals targeting the Mpro protei...
Source: B.1.1.529 Variant  Nov 26, 2021  2 years ago
Preliminary research data emerging from research centres across the United States and the United Kingdom show that the B.1.1.529 variant which is likely to be designated the name Nu variant in the next few hours is 500 times more competitively infectious than the Delta variant!   The latest updates is that the new B.1.1.529 variant contains a total of 59 mutations with a total of 32 mutation...
Source: B.1.1.529  Nov 26, 2021  2 years ago
The new SARS-CoV-2 variant B.1.1.529 that has a total of more than 50 mutations on it including 30 on its spike proteins and was initially found in three countries ie Bostwana, South Africa and Hong Kong, has now also been found in Israel. https://www.thailandmedical.news/news/great-news-a-new-horrifying-sars-cov-2-variant-b-1-1529-with-a-high-number-of-worrying-mutations-has-emerged-in-time-for-t...
Source: Thailand COVID-19 News  Nov 26, 2021  2 years ago
Thailand COVID-19 News: Countries not just in Europe but across the world are going into lockdowns, banning travel and closing borders not only because of surges being reported in many countries nor about the worrisome B.1.1.529 variant, AY.104 subvariant or B.1.640 variant, but rather it is generally expected that the situation is expected to get worse due to a multitude of factors including the ...
Source: Medical News - mRNA COVID Vaccines   Nov 26, 2021  2 years ago
A new abstract published in the peer reviewed journal of the American Heart Association (AHA) journal called Circulation warns that that mRNA COVID vaccines dramatically increase endothelial inflammatory markers and acute coronary syndrome (ACS) risk! https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712   The abstract was submitted by Dr Steven R Gundry from the International Heart...
Source: Medical News - SARS-CoV-2 Antibodies  Nov 26, 2021  2 years ago
A new study by researchers from University of Copenhagen and the Copenhagen University Hospital that explored the adverse effects of SARS-CoV-2 induced antibody responses has alarmingly found that SARS-CoV-2 induced antibody-mediated complement activation and subsequent cellular priming exacerbates COVID-19 severity!   The current COVID-19 pandemic caused by the SARS-CoV-2 coronavirus contin...
Source:   Nov 25, 2021  2 years ago
A new study by researchers from Leumit Health Services-Israel, Ariel University, Ariel-Israel, Tel Aviv University-Israel, Barzilai University Medical Centre and also involving experts from the National Cancer Institute, Bethesda-USA (Why the U.S. National Cancer Institute was involved is yet another interesting aspect that we will be covering in a future article!) has found a gradual increase in ...
Source: Medical News - Anti-idiotype Antibodies  Nov 25, 2021  2 years ago
A new study by researchers from University of California-Davis has discovered that anti-idiotype antibodies produced in SARS-CoV-2 infection and vaccination causes a multitude of health conditions associated with Long COVID and vaccine side effects.   Anti-idiotype antibodies are antibodies that bind to the variable region of another antibody.   Anti-idiotype (or “Ab2”)...
Source: Medical News - B.1.1529  Nov 25, 2021  2 years ago
The SARS-CoV-2 coronavirus is preparing for the year end festive season with the advent of many new emerging variants and sub-variants...its gift to stupid mankind.   A new variant, B.1.1.529 which was discovered and labelled as horrifying by Imperial College London virologist Dr Tom Peacock, has made its debut in early November in Botswana and is now spreading extensively in South Africa. &...
Source: Medical News - SARS-CoV-2 Research  Nov 24, 2021  2 years ago
Scientists from University of Copenhagen-Denmark, Uppsala University-Sweden, Umeå University-Sweden, Karolinska Institutet-Sweden and the Institute of Cancer Research-UK have in a new study discovered a novel method of inhibiting SARS-CoV-2 infection in human cells by blocking certain protein interactions, specifically between human G3BP1/2 proteins and SARS-CoV-2 ΦxFG Peptide Motif. &n...
Source: COVID-19 Prophylactics and Therapeutics  Nov 24, 2021  2 years ago
COVID-19 Prophylactics and Therapeutics: It interesting that in the initial stages of the pandemic when mouthwashes containing certain bioactive ingredients and antivirals were proposed as prophylactics or therapeutics alongside other regiments, the mention of mouthwashes for COVID-19 were immediately deemed as fake news by certain bastard journalist, fact-checkers and even so-called experts and d...
Source: Medical News - SARS-CoV-2 Uses Tunneling Nanotubes (TNT)   Nov 24, 2021  2 years ago
A new study by researchers from Institut Pasteur-France has found that SARS-CoV-2 uses tunneling nanotubes (TNT) to spread between permissive cells and non-permissive neuronal cells.   Although SARS-CoV-2 entry into host cells is mediated by the binding of its spike glycoprotein to the angiotensin-converting enzyme 2 (ACE2) receptor which are highly expressed in several organs, these recepto...
Source: Medical News  Nov 23, 2021  2 years ago
A new study by researchers from Germany and Switzerland has found that (SARS-CoV-2) infection can directly target and cause cellular damage to the human host adrenal glands.   The researchers from Technische Universität Dresden-Germany, University of Regensburg-Germany,  University Hospital Zurich-Switzerland and the University of Zurich-Switzerland found that by targeting and...
Source: NEUROCOVID  Nov 23, 2021  2 years ago
NEUROCOVID: For a while despite past studies indicating that the SARS-CoV-2 coronavirus could infect the neurons and that was the cause of numerous neurological and also psychiatric issues arising in COVID-19 patients and also in long COVID, there was still much debate among the scientific community and the need for further concrete evidence.   A new study by researchers from the University ...